⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9161853 | 0.76 | — | — | |
| SCHEMBL145443 | 0.66 | — | — | |
| SCHEMBL2310129 | 0.64 | — | — | |
| SCHEMBL6084247 | 0.62 | — | — | |
| SCHEMBL1741550 | 0.61 | — | — | |
| Ethyne SCHEMBL432671 | 0.57 | — | — | |
| SCHEMBL23667 | 0.56 | — | — | |
| SCHEMBL28283259 | 0.55 | — | — | |
| Propyne SCHEMBL1330783 | 0.55 | — | — | |
| Propyne SCHEMBL9522893 | 0.55 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 420 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111217811-A | Fused tricyclic compound and application thereof in medicines | 广东东阳光药业有限公司 | 2020-06-02 | — | — | CN | claimed |
| EP-1266015-B1 | ECDYSONE RECEPTOR-BASED INDUCIBLE GENE EXPRESSION SYSTEM | RHEOGENE HOLDINGS INC (US) | 2006-08-30 | — | — | EP | claimed |
| CN-118234377-A | Method for improving efficacy of herbicides | 巴斯夫欧洲公司 | 2024-06-21 | — | — | CN | disclosed |
| US-11964938-B2 | 3-phenyl-4-hexynoic acid derivatives as GPR40 agonists | CELON PHARMA S.A. (PL) | 2024-04-23 | — | — | US | disclosed |
| EP-3737470-B9 | 3-PHENYL-4-HEXYNOIC ACID DERIVATIVES AS GPR40 AGONISTS | Celon Pharma Sa (PL) | 2024-03-13 | — | — | EP | disclosed |
| WO-2023238835-A1 | SILSESQUIOXANE DERIVATIVE AND METHOD FOR PRODUCING SAME, CURABLE COMPOSITION, HARD COAT AGENT, CURED PRODUCT, HARD COAT, AND BASE MATERIAL | 東亞合成株式会社 | 2023-12-14 | — | — | WO | disclosed |
| EP-4288776-A1 | COMPOSITIONS AND METHODS FOR PREVENTING NON-SPECIFIC INTERACTIONS BETWEEN POLYMER DYES-ANTIBODY CONJUGATES | Beckman Coulter, Inc. (US) | 2023-12-13 | — | — | EP | disclosed |
| WO-2023230649-A1 | COMPOUNDS | Psylo Pty Ltd (AU) | 2023-12-07 | — | — | WO | disclosed |
| CN-117043140-A | Substituted pyrrolidin-2-ones, salts thereof and their use as herbicidal active substances | 拜耳公司 | 2023-11-10 | — | — | CN | disclosed |
| WO-2023164678-A1 | AQUEOUS BASED POLYMERS FOR SILICON ANODES | ENEVATE CORPORATION (US) | 2023-08-31 | — | — | WO | disclosed |
| WO-2023115166-A1 | COMPOUNDS | Psylo Pty Ltd (AU) | 2023-06-29 | — | — | WO | disclosed |
| WO-2003031422-A1 | NOVEL BENZOTHIAZINE DERIVATIVES, THEIR PREPARATION AND USE | NEUROSEARCH A/S (DK) | 2003-04-17 | — | — | WO | disclosed |
| EP-1301514-A1 | ARYL AND HETEROARYL DIAZABICYCLOALKANES, THEIR PREPARATION AND USE | NEUROSEARCH A/S (DK) | 2003-04-16 | — | — | EP | disclosed |
| US-6545021-B1 | Including ether and ester derivatives as well as N-carbonyl derivatives | G.D. SEARLE & CO. | 2003-04-08 | — | — | US | disclosed |
| WO-2003004493-A1 | NOVEL COMPOUNDS, THEIR PREPARATION AND USE | NEUROSEARCH A/S (DK) | 2003-01-16 | — | — | WO | disclosed |
| WO-2003004010-A1 | CARBONYLAMINO DERIVATIVES USEFUL FOR OBTAINING IMMUNE REGULATION | POSEIDON PHARMACEUTICALS A/S (DK) | 2003-01-16 | — | — | WO | disclosed |
| WO-2003000696-A1 | COMBINATION THERAPY OF AN SODm AND A CORTICOSTEROID FOR PREVENTION AND/OR TREATMENT OF INFLAMMATORY DISEASE | METAPHORE PHARMACEUTICALS, INC. (US) | 2003-01-03 | — | — | WO | disclosed |
| EP-1185312-A2 | BIOMATERIALS MODIFIED WITH SUPEROXIDE DISMUTASE MIMICS | MONSANTO COMPANY (US) | 2002-03-13 | — | — | EP | disclosed |
| WO-2002002564-A1 | ARYL AND HETEROARYL DIAZABICYCLOALKANES, THEIR PREPARATION AND USE | NEUROSEARCH A/S (DK) | 2002-01-10 | — | — | WO | disclosed |
| WO-2000072893-A2 | BIOMATERIALS MODIFIED WITH SUPEROXIDE DISMUTASE MIMICS | MONSANTO COMPANY (US) | 2000-12-07 | — | — | WO | disclosed |